How to appeal a OptumRx step therapy override denial
Step therapy (also called 'fail-first') requires patients to try a plan-preferred medication and demonstrate failure or intolerance before the plan will cover the prescribed drug. This guide is specific to OptumRx appeals.
Why OptumRx denies step therapy override
OptumRx is UnitedHealth Group's pharmacy benefit manager and administers drug coverage for UHC commercial and Medicare Part D plans, plus many third-party employer groups. The appeal track mirrors UHC procedurally but is filed and decided separately from the medical benefit.
For step therapy override specifically: Step therapy (also called 'fail-first') requires patients to try a plan-preferred medication and demonstrate failure or intolerance before the plan will cover the prescribed drug. Federal and many state laws require plans to allow exception requests when the step is clinically inappropriate.
The OptumRx appeal process
Appeal levels: Coverage determination / exception request, then plan-level redetermination, then external review (IRO commercial; IRE / MAXIMUS for Part D).
Timing: Standard exception: 72 hours. Expedited: 24 hours. Redetermination filing window: 60 days for Part D, 180 days for commercial.
What we know about OptumRx: Where the medical and pharmacy benefits both touch the same therapy (e.g. provider-administered biologics), we file parallel appeals in both lanes to avoid a procedural gap.
Common OptumRx denial patterns for step therapy override
- Separate appeal track from UHC medical. An OptumRx denial is not a UHC medical denial — and vice versa. Filing the wrong appeal track is one of the most common preventable errors. We confirm whether the denial originated at the pharmacy benefit or the medical benefit before filing.
- Specialty drug routing through BriovaRx / Optum Specialty. Specialty injectables and infused biologics often route through Optum's specialty pharmacy. Denials at this layer require formulary-exception documentation with clinical rationale, prior-trial data, and (where applicable) FDA-label citation.
- Part D coverage determinations. OptumRx-administered Part D plans follow the federal 5-level Part D appeal ladder. The IRE for Part D escalation is MAXIMUS Federal Services. Tiering and formulary exceptions are filed before a coverage-determination challenge.
The reversal pathway for step therapy override appeals
Successful step therapy override appeals against OptumRx typically require:
- Procedural-rights anchor. Every OptumRx denial triggers ERISA § 503 or 45 C.F.R. § 147.136 procedural rights. The cover letter must invoke these in the opening paragraph to lock the timeline and force criteria disclosure.
- Criteria-disclosure demand. OptumRx (like all major insurers) frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Federal law requires they disclose on request — and once they do, the criteria become the rebuttal map.
- Treating-provider attestation. A letter from the treating physician explaining medical necessity in the specific terms the carrier's policy uses. This is the single strongest evidentiary element.
- Peer-reviewed citations. At least two journal citations (NEJM, JAMA, Lancet, etc.) or specialty-society guidelines (NCCN, AASM, ACR Appropriateness Criteria) supporting the requested service for the patient's clinical profile.
- Plan-language anchor. The specific policy section that controls the determination, quoted verbatim with policy section number.
- Requested action. Clear, specific request for reversal — not a general "please reconsider."
What Apellica does for OptumRx step therapy override appeals
We file appeals against OptumRx specifically configured to its internal review process. Every appeal includes the criteria-disclosure demand, the procedural-rights anchor, treating-provider attestation language, and the specific peer-reviewed citations relevant to the denied service.
Cost: $0 upfront. We work on contingency for OptumRx appeals — if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.
Start your OptumRx step therapy override appeal
Submit a 2-minute intake. A senior reviewer responds within one business day with the specific appeal strategy for your case.
Start free appeal review →Related OptumRx guides
- OptumRx surgery denials appeal guide
- OptumRx mri and imaging denials appeal guide
- OptumRx medication and prescription denials appeal guide
- OptumRx medicare denials appeal guide